STOCK TITAN
  1. Home
  2. AMHCU

Jasper Therapeutics Stock Price, News & Analysis

AMHCU NASDAQ

Company Description

Jasper Therapeutics (NASDAQ: AMHCU) is a publicly traded company.

AMHCU stock has gained 58.1% over the past year.

This page provides a comprehensive overview of AMHCU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
+58.06%
Performance 1 year
$0.0
Market Cap
10.0M
Shares outstanding

Jasper Therapeutics (AMHCU) stock. Over the past 12 months, the stock has gained 58.1%.

Latest News

View All
—

Jasper Therapeutics Closes Transaction With Amplitude Healthcare Acquisition Corporation, Creating a Publicly Traded Biotechnology Company Dedicated to Enabling Cures Through Hematopoietic Stem Cell Therapy

acquisition
+37.77%

Amplitude Healthcare Acquisition Corporation Announces Shareholder Approval of Business Combination with Jasper Therapeutics, Inc.

acquisition
+0.19%

Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Two New Board Members

management acquisition
+3.68%

Jasper Therapeutics and Amplitude Healthcare Acquisition Corporation Announce Merger to Create a Publicly Listed Leading Biotechnology Company in Hematopoietic Stem Cell Transplantation

acquisition

Jasper Therapeutics has 4 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 0 with negative movement. Key topics include acquisition, management. View all AMHCU news →

SEC Filings

View All

No SEC filings available for AMHCU.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months